A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.
Platform Response and Material Removal
According to the social media company, the platform has taken down problematic material and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Research also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.
After moments of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.
Product Details and Costs
Inside these communities, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already encountered patients harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly serious health risks”.
